BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 17662024)

  • 21. The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction.
    Arafa M; Eid H; El-Badry A; Ezz-Eldine K; Shamloul R
    Int J Impot Res; 2007; 19(2):213-7. PubMed ID: 16915304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deformity stabilization and improvement in men with untreated Peyronie's disease.
    Berookhim BM; Choi J; Alex B; Mulhall JP
    BJU Int; 2014 Jan; 113(1):133-6. PubMed ID: 24053665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does testosterone deficiency exaggerate the clinical symptoms of Peyronie's disease?
    Nam HJ; Park HJ; Park NC
    Int J Urol; 2011 Nov; 18(11):796-800. PubMed ID: 21883492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease.
    Kadioğlu A; Tefekli A; Erol H; Cayan S; Kandirali E
    Int J Impot Res; 2000 Oct; 12(5):263-7. PubMed ID: 11424963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peyronie's disease.
    Pryor J; Akkus E; Alter G; Jordan G; Lebret T; Levine L; Mulhall J; Perovic S; Ralph D; Stackl W
    J Sex Med; 2004 Jul; 1(1):110-5. PubMed ID: 16422991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction.
    Jarow JP; Lowe FC
    J Urol; 1997 Oct; 158(4):1388-90. PubMed ID: 9302127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease.
    Usta MF; Bivalacqua TJ; Jabren GW; Myers L; Sanabria J; Sikka SC; Hellstrom WJ
    J Urol; 2004 Feb; 171(2 Pt 1):775-9. PubMed ID: 14713809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the clinical characteristics of Peyronie's disease in young men.
    Deveci S; Hopps CV; O'Brien K; Parker M; Guhring P; Mulhall JP
    J Sex Med; 2007 Mar; 4(2):485-90. PubMed ID: 17081219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of degree of penile curvature between patient estimates and objective measures among men with Peyronie's disease.
    Bacal V; Rumohr J; Sturm R; Lipshultz LI; Schumacher M; Grober ED
    J Sex Med; 2009 Mar; 6(3):862-5. PubMed ID: 19284472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of complex curvature in Peyronie's disease.
    Kadıoğlu A; Gürcan M; Rakhmonovich AF; Dursun M
    World J Urol; 2024 Apr; 42(1):276. PubMed ID: 38689034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis.
    Maremanda AP; Du Comb W; Able C; Kohn TP; Unal S; Burnett AL
    Int J Impot Res; 2024 Apr; 36(2):125-128. PubMed ID: 37542153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction.
    Chung E; Yan H; De Young L; Brock GB
    BJU Int; 2012 Oct; 110(8):1201-5. PubMed ID: 22313546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The most commonly altered type of Peyronie's disease deformity under oral colchicine treatment is lateral curvature that mostly shifts to the dorsal side.
    Akman T; Sanli O; Uluocak N; Akbulut F; Nane I; Demir S; Kadioglu A
    Andrologia; 2011 Feb; 43(1):28-33. PubMed ID: 21219379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus is associated with severe Peyronie's disease.
    Kendirci M; Trost L; Sikka SC; Hellstrom WJ
    BJU Int; 2007 Feb; 99(2):383-6. PubMed ID: 17313425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordance between patient and physician assessment of the magnitude of Peyronie's disease curvature.
    Matsushita K; Stember DS; Nelson CJ; Mulhall JP
    J Sex Med; 2014 Jan; 11(1):205-10. PubMed ID: 24119178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of penile curvature in Peyronie's disease patients: comparison of three methods.
    Ohebshalom M; Mulhall J; Guhring P; Parker M
    J Sex Med; 2007 Jan; 4(1):199-203. PubMed ID: 17233785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.